Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $39.1600 (-4.56%) ($39.1250 - $39.1600) on Thu. Sep. 7, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.11% (three month average) | RSI | 32 | Latest Price | $39.1600(-4.56%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO declines -1.8% a day on average for past five trading days. | Weekly Trend | HALO declines -1.7% a week on average for past two weeks. | Market Behavior | Growth stock sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) SPY(76%) IGOV(62%) QQQ(53%) XLF(51%) XRT(51%) | Factors Impacting HALO price | HALO will decline at least -1.055% in a week (0% probabilities). INDA(-40%) VXX(-36%) TBT(-28%) UUP(-23%) VIXM(-16%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.055% (StdDev 2.11%) | Hourly BBV | -1.7 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $36.76(-6.13%) | Resistance Level | $42.53 | 5 Day Moving Average | $41.3(-5.18%) | 10 Day Moving Average | $41.91(-6.56%) | 20 Day Moving Average | $42.53(-7.92%) | To recent high | -11.1% | To recent low | 16.2% | Market Cap | $5.352b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |